{"drug1_id": "DDInter1855", "drug1_name": "Triamcinolone", "drug1_smiles": "[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C", "drug2_id": "DDInter1879", "drug2_name": "Triprolidine", "drug2_smiles": "CC1=CC=C(C=C1)C(=C/CN1CCCC1)\\C1=CC=CC=N1", "label": false, "severity": null, "mechanism": [], "ddinter_explanation": "DRUG1 is a glucocorticoid used to treat a wide variety of inflammatory conditions of organ systems and tissues. DRUG2 is a sedating antihistamine combined with pseudoephedrine and guaifenesin in various types of cold and allergy medications to relieve allergy symptoms, hay fever and common cold symptoms, and to aid in sleep. There were no known direct interactions reported between them.", "drugbank_explanation": "DRUG1 is a glucocorticoid used to treat a wide variety of inflammatory conditions of organ systems and tissues. DRUG2 is a sedating antihistamine combined with pseudoephedrine and guaifenesin in various types of cold and allergy medications to relieve allergy symptoms, hay fever and common cold symptoms, and to aid in sleep. There were no known direct interactions reported between them.", "ddinter_exp_id": "0", "drugbank_exp_id": "0"}
{"drug1_id": "DDInter1927", "drug1_name": "Venlafaxine", "drug1_smiles": "COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1", "drug2_id": "DDInter1124", "drug2_name": "Maprotiline", "drug2_smiles": "CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21", "label": true, "severity": "Major", "mechanism": ["Synergy"], "ddinter_explanation": "Concomitant use of agents with serotonergic activity such as serotonin reuptake inhibitors, monoamine oxidase inhibitors, tricyclic antidepressants, 5-HT1 receptor agonists, ergot alkaloids, cyclobenzaprine, lithium, St. John's wort, phenylpiperidine opioids, dextromethorphan, and tryptophan may potentiate the risk of serotonin syndrome, which is a rare but serious and potentially fatal condition thought to result from hyperstimulation of brainstem 5-HT1A and 2A receptors. Symptoms of the serotonin syndrome may include mental status changes such as irritability, altered consciousness, confusion, hallucination, and coma; autonomic dysfunction such as tachycardia, hyperthermia, diaphoresis, shivering, blood pressure lability, and mydriasis; neuromuscular abnormalities such as hyperreflexia, myoclonus, tremor, rigidity, and ataxia; and gastrointestinal symptoms such as abdominal cramping, nausea, vomiting, and diarrhea.", "drugbank_explanation": "The risk or severity of serotonin syndrome can be increased when DRUG2 is combined with DRUG1.", "ddinter_exp_id": "21", "drugbank_exp_id": "16"}
{"drug1_id": "DDInter124", "drug1_name": "Ascorbic acid", "drug1_smiles": "[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO", "drug2_id": "DDInter562", "drug2_name": "Dimenhydrinate", "drug2_smiles": "CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1", "label": false, "severity": null, "mechanism": [], "ddinter_explanation": "Vitamin C is a vitamin used to correct vitamin C deficiency and to increase the intestinal absorption of iron. DRUG2 is a medication used to prevent and treat nausea, vomiting, vertigo, and motion sickness. There were no known direct interactions reported between them.", "drugbank_explanation": "Vitamin C is a vitamin used to correct vitamin C deficiency and to increase the intestinal absorption of iron. DRUG2 is a medication used to prevent and treat nausea, vomiting, vertigo, and motion sickness. There were no known direct interactions reported between them.", "ddinter_exp_id": "0", "drugbank_exp_id": "0"}
{"drug1_id": "DDInter349", "drug1_name": "Chloral hydrate", "drug1_smiles": "OC(O)C(Cl)(Cl)Cl", "drug2_id": "DDInter1073", "drug2_name": "Linezolid", "drug2_smiles": "CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1", "label": false, "severity": null, "mechanism": [], "ddinter_explanation": "DRUG1 is a mild hypnotic used for experimental purposes that was previously used for the treatment of insomnia. DRUG2 is an oxazolidinone antibiotic used to treat infections by susceptible strains of aerobic Gram-positive bacteria. There were no known direct interactions reported between them.", "drugbank_explanation": "DRUG1 is a mild hypnotic used for experimental purposes that was previously used for the treatment of insomnia. DRUG2 is an oxazolidinone antibiotic used to treat infections by susceptible strains of aerobic Gram-positive bacteria. There were no known direct interactions reported between them.", "ddinter_exp_id": "0", "drugbank_exp_id": "0"}
{"drug1_id": "DDInter624", "drug1_name": "Efavirenz", "drug1_smiles": "FC(F)(F)[C@]1(OC(=O)NC2=C1C=C(Cl)C=C2)C#CC1CC1", "drug2_id": "DDInter3", "drug2_name": "Abametapir (topical)", "drug2_smiles": "CC1=CC=C(N=C1)C1=CC=C(C)C=N1", "label": true, "severity": "Moderate", "mechanism": ["Metabolism"], "ddinter_explanation": "Based on in vitro inhibition data, a single topical application of DRUG2 lotion may increase plasma concentrations of drugs that are substrates of CYP450 3A4, CYP450 2B6, and CYP450 1A2 isoenzymes and increase their systemic concentrations. The proposed mechanism is high and prolonged systemic exposure to the metabolite DRUG2 carboxyl, which has been shown to be an in vitro inhibitor of CYP450 3A4, CYP450 2B6, and CYP450 1A2.", "drugbank_explanation": "The serum concentration of DRUG1 can be increased when it is combined with DRUG2.", "ddinter_exp_id": "28", "drugbank_exp_id": "4"}
{"drug1_id": "DDInter1716", "drug1_name": "Succinylcholine", "drug1_smiles": "C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C", "drug2_id": "DDInter1114", "drug2_name": "Magnesium chloride", "drug2_smiles": "[Mg++].[Cl-].[Cl-]", "label": true, "severity": "Moderate", "mechanism": ["Synergy"], "ddinter_explanation": "Magnesium salts may enhance the effects of nondepolarizing neuromuscular blocking agents. One study showed a 25% increase in vecuronium potency after intravenous administration of 40 mg/kg of magnesium sulfate.", "drugbank_explanation": "The therapeutic efficacy of DRUG1 can be increased when used in combination with DRUG2.", "ddinter_exp_id": "2009", "drugbank_exp_id": "11"}
{"drug1_id": "DDInter71", "drug1_name": "Aminoglutethimide", "drug1_smiles": "CCC1(CCC(=O)NC1=O)C1=CC=C(N)C=C1", "drug2_id": "DDInter1897", "drug2_name": "Ulipristal", "drug2_smiles": "CN(C)C1=CC=C(C=C1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12", "label": true, "severity": "Moderate", "mechanism": ["Metabolism"], "ddinter_explanation": "The concomitant use of CYP450 3A4 inducers may decrease the plasma concentrations and efficacy of DRUG2, which is primarily metabolized by the isoenzyme. Induction of CYP450 3A4 may last for up to 4 weeks after discontinuation of the enzyme inducer.", "drugbank_explanation": "The metabolism of DRUG2 can be increased when combined with DRUG1.", "ddinter_exp_id": "598", "drugbank_exp_id": "6"}
{"drug1_id": "DDInter11", "drug1_name": "Acarbose", "drug1_smiles": "[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO", "drug2_id": "DDInter1353", "drug2_name": "Ospemifene", "drug2_smiles": "OCCOC1=CC=C(C=C1)C(=C(\\CCCl)C1=CC=CC=C1)\\C1=CC=CC=C1", "label": false, "severity": null, "mechanism": [], "ddinter_explanation": "DRUG1 is an alpha-glucosidase inhibitor used in adjunctly with diet and exercise for the management of glycemic control in patients with type 2 diabetes mellitus. DRUG2 is a non-hormonal estrogen receptor modulator (SERM) used to treat moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. There were no known direct interactions reported between them.", "drugbank_explanation": "DRUG1 is an alpha-glucosidase inhibitor used in adjunctly with diet and exercise for the management of glycemic control in patients with type 2 diabetes mellitus. DRUG2 is a non-hormonal estrogen receptor modulator (SERM) used to treat moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. There were no known direct interactions reported between them.", "ddinter_exp_id": "0", "drugbank_exp_id": "0"}
{"drug1_id": "DDInter380", "drug1_name": "Cimetidine", "drug1_smiles": "CN\\C(NCCSCC1=C(C)NC=N1)=N\\C#N", "drug2_id": "DDInter1236", "drug2_name": "Modafinil", "drug2_smiles": "NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1", "label": true, "severity": "Minor", "mechanism": ["Metabolism"], "ddinter_explanation": "Coadministration with inhibitors of CYP450 3A4 may increase the plasma concentrations of DRUG2 (the racemate) and arDRUG2 (the R-enantiomer), which are both partially metabolized by the isoenzyme. Conversely, the plasma levels of some of these inhibitors may decrease, since many of them are also substrates of CYP450 3A4, and DRUG2 and arDRUG2 have been found to be modest inducers of CYP450 3A4. The clinical significance of this potential interaction is unknown. Clinical monitoring for altered effects of DRUG2 and arDRUG2 as well as the CYP450 3A4 inhibitor may be appropriate following addition or withdrawal of one or the other drug.", "drugbank_explanation": "The metabolism of DRUG2 can be decreased when combined with DRUG1.", "ddinter_exp_id": "504", "drugbank_exp_id": "1"}
{"drug1_id": "DDInter1286", "drug1_name": "Niacin", "drug1_smiles": "OC(=O)C1=CN=CC=C1", "drug2_id": "DDInter1785", "drug2_name": "Tetraferric tricitrate decahydrate", "drug2_smiles": "O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O", "label": false, "severity": null, "mechanism": [], "ddinter_explanation": "DRUG1 is a B vitamin used to treat hypertriglyceridemia and pellagra. Ferric citrate is a phosphate binder used to control serum phosphorus levels or as an iron supplement. There were no known direct interactions reported between them.", "drugbank_explanation": "DRUG1 is a B vitamin used to treat hypertriglyceridemia and pellagra. Ferric citrate is a phosphate binder used to control serum phosphorus levels or as an iron supplement. There were no known direct interactions reported between them.", "ddinter_exp_id": "0", "drugbank_exp_id": "0"}
{"drug1_id": "DDInter695", "drug1_name": "Ethosuximide", "drug1_smiles": "CCC1(C)CC(=O)NC1=O", "drug2_id": "DDInter1789", "drug2_name": "Thalidomide", "drug2_smiles": "O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12", "label": true, "severity": "Moderate", "mechanism": ["Synergy"], "ddinter_explanation": "DRUG2 can commonly cause drowsiness/sedation and may have additive effects with other drugs that cause central nervous system (CNS) depression.", "drugbank_explanation": "DRUG1 may increase the central nervous system depressant (CNS depressant) activities of DRUG2.", "ddinter_exp_id": "97", "drugbank_exp_id": "5"}
{"drug1_id": "DDInter78", "drug1_name": "Amitriptyline", "drug1_smiles": "CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12", "drug2_id": "DDInter1146", "drug2_name": "Memantine", "drug2_smiles": "CC12CC3CC(C)(C1)CC(N)(C3)C2", "label": true, "severity": "Moderate", "mechanism": ["Synergy"], "ddinter_explanation": "Agents with anticholinergic properties (e.g., sedating antihistamines; antispasmodics; neuroleptics; phenothiazines; skeletal muscle relaxants; tricyclic antidepressants; disopyramide) may have additive effects when used in combination. Excessive parasympatholytic effects may result in paralytic ileus, hyperthermia, heat stroke, and the anticholinergic intoxication syndrome. Peripheral symptoms of intoxication commonly include mydriasis, blurred vision, flushed face, fever, dry skin and mucous membranes, tachycardia, urinary retention, and constipation. Central symptoms may include memory loss, disorientation, incoherence, hallucinations, psychosis, delirium, hyperactivity, twitching or jerking movements, stereotypy, and seizures. Central nervous system-depressant effects may also be additively or synergistically increased when these agents are combined, especially in elderly or debilitated patients.", "drugbank_explanation": "The metabolism of DRUG1 can be decreased when combined with DRUG2.", "ddinter_exp_id": "3", "drugbank_exp_id": "1"}
{"drug1_id": "DDInter1031", "drug1_name": "Ledipasvir", "drug1_smiles": "COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1C1=NC(=CN1)C1=CC=C2C3=CC=C(C=C3C(F)(F)C2=C1)C1=CC=C2NC(=NC2=C1)[C@@H]1[C@H]2CC[C@H](C2)N1C(=O)[C@@H](NC(=O)OC)C(C)C", "drug2_id": "DDInter1084", "drug2_name": "Lomefloxacin", "drug2_smiles": "CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCNC(C)C3)C(F)=C12", "label": false, "severity": null, "mechanism": [], "ddinter_explanation": "DRUG1 is a direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. DRUG2 is a fluoroquinolone used to prevent and treat a wide variety of infections in the body. There were no known direct interactions reported between them.", "drugbank_explanation": "DRUG1 is a direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. DRUG2 is a fluoroquinolone used to prevent and treat a wide variety of infections in the body. There were no known direct interactions reported between them.", "ddinter_exp_id": "0", "drugbank_exp_id": "0"}
{"drug1_id": "DDInter319", "drug1_name": "Cefixime", "drug1_smiles": "[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC(O)=O)\\C1=CSC(N)=N1)C(O)=O", "drug2_id": "DDInter889", "drug2_name": "Hydroflumethiazide", "drug2_smiles": "NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1C(F)(F)F", "label": false, "severity": null, "mechanism": [], "ddinter_explanation": "DRUG1 is a third generation cephalosporin used to treat susceptible Gram negative and Gram positive bacterial infections. DRUG2 is a thiazide diuretic used to treat hypertension as well as edema due to congestive heart failure and liver cirrhosis. There were no known direct interactions reported between them.", "drugbank_explanation": "DRUG1 is a third generation cephalosporin used to treat susceptible Gram negative and Gram positive bacterial infections. DRUG2 is a thiazide diuretic used to treat hypertension as well as edema due to congestive heart failure and liver cirrhosis. There were no known direct interactions reported between them.", "ddinter_exp_id": "0", "drugbank_exp_id": "0"}
{"drug1_id": "DDInter124", "drug1_name": "Ascorbic acid", "drug1_smiles": "[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO", "drug2_id": "DDInter1552", "drug2_name": "Quazepam", "drug2_smiles": "FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2", "label": false, "severity": null, "mechanism": [], "ddinter_explanation": "Vitamin C is a vitamin used to correct vitamin C deficiency and to increase the intestinal absorption of iron. DRUG2 is a long -acting benzodiazepine used to manage insomnia. There were no known direct interactions reported between them.", "drugbank_explanation": "Vitamin C is a vitamin used to correct vitamin C deficiency and to increase the intestinal absorption of iron. DRUG2 is a long -acting benzodiazepine used to manage insomnia. There were no known direct interactions reported between them.", "ddinter_exp_id": "0", "drugbank_exp_id": "0"}
{"drug1_id": "DDInter95", "drug1_name": "Anastrozole", "drug1_smiles": "CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N", "drug2_id": "DDInter512", "drug2_name": "Deutetrabenazine", "drug2_smiles": "[2H]C([2H])([2H])OC1=CC2=C(C=C1OC([2H])([2H])[2H])[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2", "label": false, "severity": null, "mechanism": [], "ddinter_explanation": "DRUG1 is a competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of hormone receptor-positive breast cancer in postmenopausal women. DRUG2 is a vesicular monoamine transporter 2 inhibitor used for the symptomatic treatment of chorea in Huntington's disease and tardive dyskinesia. There were no known direct interactions reported between them.", "drugbank_explanation": "DRUG1 is a competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of hormone receptor-positive breast cancer in postmenopausal women. DRUG2 is a vesicular monoamine transporter 2 inhibitor used for the symptomatic treatment of chorea in Huntington's disease and tardive dyskinesia. There were no known direct interactions reported between them.", "ddinter_exp_id": "0", "drugbank_exp_id": "0"}
{"drug1_id": "DDInter1531", "drug1_name": "Proguanil", "drug1_smiles": "CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1", "drug2_id": "DDInter1707", "drug2_name": "Spironolactone", "drug2_smiles": "[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O", "label": false, "severity": null, "mechanism": [], "ddinter_explanation": "DRUG1 is a medication indicated for prophylaxis and treatment of Plasmodium falciparum malaria. DRUG2 is an aldosterone receptor antagonist used for the treatment of hypertension, hyperaldosteronism, edema due to various conditions, hirsutism (off-label) and hypokalemia. There were no known direct interactions reported between them.", "drugbank_explanation": "DRUG1 is a medication indicated for prophylaxis and treatment of Plasmodium falciparum malaria. DRUG2 is an aldosterone receptor antagonist used for the treatment of hypertension, hyperaldosteronism, edema due to various conditions, hirsutism (off-label) and hypokalemia. There were no known direct interactions reported between them.", "ddinter_exp_id": "0", "drugbank_exp_id": "0"}
{"drug1_id": "DDInter8", "drug1_name": "Abiraterone", "drug1_smiles": "[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C", "drug2_id": "DDInter797", "drug2_name": "Gadoteric acid", "drug2_smiles": "[Gd+3].OC(=O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1", "label": false, "severity": null, "mechanism": [], "ddinter_explanation": "DRUG1 is an antiandrogen used in the treatment of prostate cancer. DRUG2 is a diagnostic contrast agent used with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging. There were no known direct interactions reported between them.", "drugbank_explanation": "DRUG1 is an antiandrogen used in the treatment of prostate cancer. DRUG2 is a diagnostic contrast agent used with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging. There were no known direct interactions reported between them.", "ddinter_exp_id": "0", "drugbank_exp_id": "0"}
{"drug1_id": "DDInter822", "drug1_name": "Glasdegib", "drug1_smiles": "CN1CC[C@H](C[C@@H]1C1=NC2=CC=CC=C2N1)NC(=O)NC1=CC=C(C=C1)C#N", "drug2_id": "DDInter1750", "drug2_name": "Tazemetostat", "drug2_smiles": "CCN(C1CCOCC1)C1=C(C)C(=CC(=C1)C1=CC=C(CN2CCOCC2)C=C1)C(=O)NCC1=C(C)C=C(C)NC1=O", "label": true, "severity": "Moderate", "mechanism": ["Absorption"], "ddinter_explanation": "Coadministration with DRUG1 may increase the plasma concentrations of drugs that are substrates of the P-glycoprotein (P-gp) and/or breast cancer resistance protein (BCRP) efflux transporters.", "drugbank_explanation": "DRUG1 may decrease the excretion rate of DRUG2 which could result in a higher serum level.", "ddinter_exp_id": "513", "drugbank_exp_id": "8"}
{"drug1_id": "DDInter951", "drug1_name": "Iobenguane (I-123)", "drug1_smiles": "NC(N)=NCC1=CC(I)=CC=C1", "drug2_id": "DDInter1898", "drug2_name": "Ulobetasol (topical)", "drug2_smiles": "[H][C@@]12C[C@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C", "label": false, "severity": null, "mechanism": [], "ddinter_explanation": "DRUG1 is a radiopharmaceutical agent used for the diagnosis of primary and metastatic pheochromocytoma or neuroblastoma. DRUG2 is a lipocortin corticosteroid used to treat inflammatory and pruritic corticosteroid-responsive dermatoses. There were no known direct interactions reported between them.", "drugbank_explanation": "DRUG1 is a radiopharmaceutical agent used for the diagnosis of primary and metastatic pheochromocytoma or neuroblastoma. DRUG2 is a lipocortin corticosteroid used to treat inflammatory and pruritic corticosteroid-responsive dermatoses. There were no known direct interactions reported between them.", "ddinter_exp_id": "0", "drugbank_exp_id": "0"}